The beloved actor says she will be receiving the best treatment available for the stage 4 cancer.
Articles on Cancer
Displaying 141 - 160 of 1114 articles
People with disability are more likely to die from cancer than the overall population. Here’s how we can shift this striking inequity.
The G20 should acknowledge that diseases like high blood pressure and type 2 diabetes are part of a system in which commercial actors are causing ill health.
Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.
Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.
CAR-T cells are 1,000 times more effective at destroying cancer than our own immune systems.
With bone metastasis and a high Gleason score, Biden’s case is a reminder of the importance of timely screening and comprehensive care.
Here’s what clinicians consider when they calculate a prostate cancer’s Gleason score.
Study shows how small changes make a big difference when it comes to physical activity and reducing cancer risk.
As breast cancer screening evolves, understanding personal risk factors like density is critical for improving early detection.
Optical fibres are now being used to monitor radiation therapy with hair-thin precision – making treatments safer and more effective for cancer patients.
Saliva testing makes diagnostics cheaper faster and easier.
While low levels of vitamin D are linked with increased risk of CRC, there are no definitive answers. Here’s what we know—and why lifestyle still matters most.
Tina Knowles’ breast cancer diagnosis highlights a critical issue: many early-stage cancers are only caught through routine screenings.
Research suggests diet and E coli infections in childhood could be laying the ground for agressive bowel cancer decades later.
Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death rates. This may soon no longer be the case.
Some patients with a terminal illness seem to be able to ‘hold on’ until after an anticipated holiday or event. This might be less about staying positive and more about being supported in your goals.
While AI holds promise for improving breast cancer screening, we should proceed cautiously.
CT scans performed in the US in 2023 alone could eventually lead to over 100,000 extra cancer cases, a new study claims.
Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer that’s spread or can’t be removed by surgery.
Top contributors
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Professor, Department of Biomedical and Life Sciences, Lancaster University
-
Senior Lecturer in Cancer Biology & Clinical Biochemistry, Kingston University
-
Senior Lecturer in Genetics and Molecular Biology, Kingston University
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Professor, School of Medicine, University of Connecticut
-
Associate professor, University of Sydney
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Graduate Student in Cancer Systems Biology, Rice University
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney